FStar Therapeutics
$7.12
5
-$0.00-0.07% Wednesday 20:55
Statistics
Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
156.4M
P/E Ratio
0
Dividend Yield
-
Dividend
-
Earnings
13MarExpected
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Q3 2022
Q4 2022
-0.92
-0.45
0.01
0.48
Expected EPS
-0.51
Actual EPS
N/A
Financials
-149.14%Profit Margin
Unprofitable21.17MRevenue
-31.57MNet Income
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Health Technology
Pharmaceuticals: Major
Manufacturing
Pharmaceutical Preparation Manufacturing
F-star Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops tetravalent bispecific antibodies for cancer therapy. Its medicines are used in immuno-oncology treatments. The company's principal product candidate is FS118 and is being evaluated in a proof-of-concept Phase 2 trial in PD-1/PD-L1 acquired resistance head and neck cancer patients. It is also developing first-in-human clinical study of FS222, a bispecific antibody that is in Phase 1 clinical trial targeting the costimulatory CD137 receptor and the inhibitory PD-L1 ligand. In addition, the company is also evaluating FS120 and SB 11285 for patients with advanced cancers, which are under Phase 1 clinical trials. F-star Therapeutics, Inc. was incorporated in 2002 and is headquartered in Cambridge, the United Kingdom.
Show more...
CEO
Employees
84
Country
United States
ISIN
US30315R1077
WKN
000A2QJEK
Listings
0 Comments
Share your thoughts
FAQ
What is FStar Therapeutics stock price today?▼
The current price of FSTX is $7.12 USD — it has decreased by -0.07% in the past 24 hours. Watch FStar Therapeutics stock price performance more closely on the chart.
What is FStar Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange FStar Therapeutics stocks are traded under the ticker FSTX.
What is FStar Therapeutics market cap?▼
Today FStar Therapeutics has the market capitalization of 156.4M
What is FStar Therapeutics revenue for the last year?▼
FStar Therapeutics revenue for the last year amounts to 21.17M USD.
What is FStar Therapeutics net income for the last year?▼
FSTX net income for the last year is -31.57M USD.
How many employees does FStar Therapeutics have?▼
As of September 30, 2026, the company has 84 employees.
In which sector is FStar Therapeutics located?▼
FStar Therapeutics operates in the Manufacturing sector.
When did FStar Therapeutics complete a stock split?▼
The last stock split for FStar Therapeutics was on November 23, 2020 with a ratio of 1:4.
Where is FStar Therapeutics headquartered?▼
FStar Therapeutics is headquartered in Hopkinton, United States.